Samsung Electronics Co., Ltd.

Seoul National University

Thedonee Inc.

Kang Won Lee

Myeong Lo Lee

Hyung Min Yook

Sung Sik Yoo

Yong Ki Min

Young Ae Kang

Hui Chul Yang

Jong Ju Park

Cheol Ki Min

Hyon Seok Song

Sara Lee

Yoon Jeong

Sun Mi Lee

Se Youp Chu

Jong Wu Baek

Eun Yeung Lee

Hui Chui Yang

Seung Kwon Park

Kyung Hwan Moon

Min Hee Park

Chae Won Bae

Sa Ra Lee

A method of supporting divided screen areas and a mobile terminal employing the same are disclosed. The method includes: generating input signals for one of sequentially and simultaneously activating a plurality of user functions; activating the user functions according to generated input signals; dividing a screen into divided screen areas that correspond to activated user functions; and outputting functional view areas associated with the activated user functions to the corresponding divided screen areas.

Method of dividing screen areas and mobile terminal employing the same

The present invention relates to a method for producing an alginic acid-folic acid conjugate, an alginic acid-folic acid conjugate produced thereby, and a pharmaceutical composition containing the same. According to the method of producing an alginic acid-folic acid conjugate using a carboxy-protecting group and a leaving group, the hydroxyl group of alginic acid forms an ester group with the carboxyl group of folic acid. Thus, the alginic acid-folic acid conjugate may clearly distinguish cancer cells from normal tissue by more effectively targeting cancer cells than a conventional alginic acid-conjugated folic acid in which the amine group of folic acid is covalently bonded to the carboxyl group of alginic acid. Accordingly, the alginic acid-folic acid conjugate may be effectively used for precise diagnosis and efficient surgical resection of cancer lesions.

Method for producing alginic acid-folic acid conjugate, alginic acid-folic acid conjugate produced thereby and pharmaceutical composition containing the same

Provided are nanoparticles for the selective death of cancer cells through ferroptosis and a method of preparing the same. More particularly, the nanoparticles are in a form in which a cancer cell-targeting hydrogel and iron particles are bound and aggregated, and are selectively accumulated in cancer cells, and thus exhibit an effective cancer cell killing effect through ferroptosis, and accordingly, are expected to exhibit high therapeutic effects due to less side effects.

Nanoparticles for selective death of cancer cells through ferroptosis, method of preparing the same, and use of the nanoparticles

A defect inspecting apparatus includes a reference image generator configured to generate a first reference image and a second reference image from design layout data. An image inspector is configured to obtain a first inspection image of a first inspection region of a photomask and a second inspection image of a second inspection region of the photomask. An operation processor is configured to extract a first coordinate offset by comparing the first inspection image with the first reference image and to extract a second coordinate offset by comparing the second inspection image with the second reference image.

Inspection apparatus for detecting defects in photomasks and dies

A strip structure for measuring potassium ions includes: a strip having an inner space for receiving a solution therein and being formed in a plate shape; an inlet formed in the strip and capable of injecting a solution into the inner space of the strip; a potassium ion selective membrane arranged in the inner space and capable of permeating potassium ions of the solution; and a first working electrode extending in a strip shape, wherein one side of the first working electrode is arranged inside the potassium ion selective membrane and the other side of the first working electrode is on a surface of the strip.

Strip structure for measuring potassium ions

An embodiment of the present invention provides a nanocarrier in a micelle structure, a pharmaceutical composition for diagnosis of cancer, comprising the same nanocarrier, and a method for preparing the same nanocarrier. The nanocarrier is obtained by dispersing a water-in-oil nanoemulsion containing an oil phase ingredient, a surfactant, and an aqueous phase ingredient inclusive of a cancer cell fluorescence-inducing substance and a cancer cell-targeting polysaccharide in water to remove the oil phase ingredient, whereby the nanocarrier includes the aqueous phase ingredient.

Nanocarrier for selective fluorescence labeling of cancer cell and preparation method therefor

One embodiment of the present invention relates to a nanoemulsion and a preparation method therefor, the nanoemulsion comprising an oil component, a surfactant, and an aqueous component, wherein the aqueous component comprises a water-soluble active ingredient, a polysaccharide, and hyaluronic acid.

Hydrogel-based nanoenulsion for selectively labeling cancer lesion, and preparation method therefor

An electronic device includes a housing, one or more input/output (I/O) interfaces included in or on the housing, a processor, and a memory, wherein the memory stores a plurality of templates associated with a plurality of tasks, wherein each of the templates includes a plurality of parameters for at least partially completing a respective one of the tasks, and wherein the memory further stores instructions that, when executed, cause the processor to: receive a user input to set up an alarm associated with a task to be performed at a selected time, wherein the input includes a first time parameter associated with the selected time; select one of the plurality of templates; determine a second time parameter of the plurality of parameters of the selected template; determine a time for the alarm; and provide the alarm at the determined time.

Method and electronic device for setting alarm

Growing community of inventors

Gyeonggi-do, South Korea

Kang Won Lee